NCT03408665View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

March 13, 2019

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2027

Conditions
Liver CancerLiver Metastases
Interventions
RADIATION

SBRT

3 sessions at least, up to 6. Neither specifc device is imposed.

Trial Locations (7)

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret, Lille

94800

Institut Gustave Roussy, Villejuif

95200

Institut de Cancérologie Paris Nord, Sarcelles

Unknown

Centre Léonard de Vinci, Dechy

Institut Régional du Cancer de Montpellier, Montpellier

Centre Paul Strauss, Strasbourg

All Listed Sponsors
collaborator

Canceropôle Nord Ouest

OTHER

lead

Centre Oscar Lambret

OTHER

NCT03408665 - Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer | Biotech Hunter | Biotech Hunter